Literature DB >> 9832173

Is there a role for the ob gene product leptin in essential hypertension?

P M Suter1, R Locher, E Häsler, W Vetter.   

Abstract

In this study we wanted to evaluate the relationship between the ob gene product leptin and blood pressure, as well as plasma renin activity and plasma aldosterone levels. We studied 139 subjects with a mean+/-SD age of 50 +/-14 years and a body mass index of 26.5+/-5.3 kg/m2; 110 subjects had essential hypertension and 29 were healthy nonhypertensive controls. Blood pressure was measured in resting conditions in the morning and blood was drawn for the determination of the plasma renin activity, aldosterone, and leptin levels. The mean blood pressure of the population was 155/97 mm Hg. The relationship between these parameters was studied by univariate regression analysis according to gender and, whenever indicated, adjusted for age and body mass. The mean+/-SEM plasma leptin level in the whole population was 9.5+/-0.6 ng/mL (range, 1.1-43.3). Subjects with stage I hypertension had significantly higher plasma leptin levels than normotensive subjects. Systolic blood pressure correlated with the plasma leptin levels and the leptin levels adjusted for body weight in women (r = 0.422, P < .01) and nonhypertensive men (r = 0.644, P = .03) only. Plasma renin activity (r = 0.329, P = .03) and aldosterone levels (r = 0.342, P = .026) correlated with the leptin concentration. A significant relationship between the peripheral expression of the ob gene product leptin and systolic blood pressure was found in women and nonhypertensive men. In view of the multiple functions of leptin a causal relationship is postulated and potential mechanisms may involve modulatory effects of leptin on neuropeptide Y, angiotensinogen gene expression, the modulation of the autonomous nervous system, or effects on the pituitary adrenal axis. Direct relationships between both plasma renin activity and aldosterone levels and leptin support the potential importance of the relationship between leptin and blood pressure. Our observation may be of future importance for the understanding of the link between the increase in blood pressure and increasing body weight.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9832173     DOI: 10.1016/s0895-7061(98)00162-9

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  14 in total

Review 1.  Pathophysiology of obesity hypertension.

Authors:  J E Hall
Journal:  Curr Hypertens Rep       Date:  2000-04       Impact factor: 5.369

2.  Obesity, blood pressure, and renal sodium handling.

Authors:  M H Weinberger
Journal:  Curr Hypertens Rep       Date:  1999 Apr-May       Impact factor: 5.369

Review 3.  Obesity and eye diseases.

Authors:  Ning Cheung; Tien Y Wong
Journal:  Surv Ophthalmol       Date:  2007 Mar-Apr       Impact factor: 6.048

Review 4.  Leptin: sympathetic and cardiovascular effects.

Authors:  Robert J Richards; Anthony Blalock; Jie Liao; Efrain Reisin
Journal:  Curr Cardiol Rep       Date:  2003-11       Impact factor: 2.931

5.  Leptin receptor (LEPR) SNP polymorphisms in HELLP syndrome patients determined by quantitative real-time PCR and melting curve analysis.

Authors:  Tibor Várkonyi; Levente Lázár; Attila Molvarec; Nándor Gábor Than; János Rigó; Bálint Nagy
Journal:  BMC Med Genet       Date:  2010-02-11       Impact factor: 2.103

6.  Leptin as an important link between obesity and cardiovascular risk factors in men with acute myocardial infarction.

Authors:  Nergis Ekmen; Aysen Helvaci; Meral Gunaldi; Hadi Sasani; Sembol Turkmen Yildirmak
Journal:  Indian Heart J       Date:  2016-01-14

Review 7.  Cardiometabolic syndrome: pathophysiology and treatment.

Authors:  Jonathan P Castro; Fadi A El-Atat; Samy I McFarlane; Ashish Aneja; James R Sowers
Journal:  Curr Hypertens Rep       Date:  2003-10       Impact factor: 5.369

8.  Leptin is associated with blood pressure and hypertension in women from the National Heart, Lung, and Blood Institute Family Heart Study.

Authors:  Duanduan Ma; Mary F Feitosa; Jemma B Wilk; Jason M Laramie; Kai Yu; Catherine Leiendecker-Foster; Richard H Myers; Michael A Province; Ingrid B Borecki
Journal:  Hypertension       Date:  2009-02-09       Impact factor: 10.190

9.  Human adipocytes secrete mineralocorticoid-releasing factors.

Authors:  M Ehrhart-Bornstein; V Lamounier-Zepter; A Schraven; J Langenbach; H S Willenberg; A Barthel; H Hauner; S M McCann; W A Scherbaum; S R Bornstein
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-12       Impact factor: 11.205

10.  Human soluble leptin receptor concentration in healthy offspring of hypertensive parents.

Authors:  Dimitris P Papadopoulos; Thomas K Makris; Maria Poulakou; Urania G Papazachou; Antonios N Hatzizacharias; Despina N Perrea; Vassilios E Votteas
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-11       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.